2. Gene
  3. Mical1 - microtubule associated monooxygenase, calponin and LIM domain containing 1 Gene

Mical1 - microtubule associated monooxygenase, calponin and LIM domain containing 1 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Mus musculus

同用名: MICAL; Nical; MICAL-1

基因 ID: 171580 | 基因类型: protein coding

关于 Mical1

功能概要

Enables several functions, including FAD binding activity; actin binding activity; and Enzyme binding activity. Involved in several processes, including actin filament depolymerization; negative regulation of cellular protein metabolic process; and sulfur oxidation. Located in hippocampal mossy fiber expansion. Orthologous to human MICAL1 (microtubule associated monooxygenase, calponin and LIM domain containing 1). [provided by Alliance of Genome Resources, Apr 2022]

Mical1 基因产物(4)

mRNA Protein Name
NM_001164433.1 NP_001157905.1 [F-actin]-monooxygenase MICAL1 isoform 2
NM_001358838.1 NP_001345767.1 [F-actin]-monooxygenase MICAL1 isoform 3
NM_001358839.1 NP_001345768.1 [F-actin]-monooxygenase MICAL1 isoform 4
NM_138315.2 NP_612188.1 [F-actin]-monooxygenase MICAL1 isoform 1
基因本体论
  • 分子功能
  • 生物过程
  • 细胞组分
分子功能 GO 注释 逻辑证据 参考文献 来源
enables FAD binding IDA
IDA: 通过直接分析推断
26935886 MGI
enables actin binding IDA
IDA: 通过直接分析推断
23911929 MGI
enables monooxygenase activity IMP
IMP: 通过突变表型推断
16275926 MGI
enables oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen IDA
IDA: 通过直接分析推断
23911929 MGI
enables protein binding IPI
IPI: 通过物理相互作用推断
21730291 MGI
enables protein kinase binding IDA
IDA: 通过直接分析推断
25007825 MGI
enables small GTPase binding IPI
IPI: 通过物理相互作用推断
18094055 MGI
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in actin filament depolymerization IDA
IDA: 通过直接分析推断
23911929 MGI
involved in negative regulation of apoptotic process IMP
IMP: 通过突变表型推断
21730291 MGI
involved in negative regulation of cysteine-type endopeptidase activity involved in apoptotic process IMP
IMP: 通过突变表型推断
21730291 MGI
involved in negative regulation of protein phosphorylation IMP
IMP: 通过突变表型推断
21730291 MGI
involved in regulation of regulated secretory pathway IMP
IMP: 通过突变表型推断
25007825 MGI
involved in sulfur oxidation IDA
IDA: 通过直接分析推断
23911929 MGI
细胞组分 GO 注释 逻辑证据 参考文献 来源
located in hippocampal mossy fiber expansion IMP
IMP: 通过突变表型推断
25007825 MGI
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

[F-actin]-monooxygenase MICAL1

F-actin-monooxygenase MICAL1

CasL interacting molecule MICAL

NEDD9-interacting protein with calponin homology and LIM domains

[F-actin]-methionine sulfoxide oxidase MICAL1

microtubule associated monoxygenase, calponin and LIM domain containing 1

molecule interacting with CasL pro

Mical1 蛋白互作信息

分类
蛋白名称 蛋白编号 互作蛋白 互作蛋白种属 互作蛋白编号 实验方法 参考文献
种属内
Mical1 Q8VDP3 Stk38 Mus musculus Q91VJ4
Anti Tag CoIP
21730291
种属间
Mical1 Q8VDP3 Stk38l Rattus norvegicus A4GW50
Anti Tag CoIP
21730291
种属间: 跨种属相互作用 种属内: 同种属相互作用

相关产品

Approval
生物活性分子 (23)
目录号 产品名 作用方式
纯度 是否罕见病
HY-12678 Entrectinib 99.79% 是
HY-109506 DPPC 99.84% 否
HY-N1428 Citric acid Inducer ≥98.0% 是
HY-109044 Tapinarof Agonist 99.95% 否
HY-B1192 Estradiol benzoate Agonist 99.89% 否
HY-B2201 Citric acid trisodium Inducer ≥98.0% 否
HY-B0448 Phenytoin Inhibitor 99.91% 是
HY-124290 Carotegrast methyl Antagonist 98.89% 否
HY-B0448A Phenytoin sodium Inhibitor 99.84% 是
HY-147080 Avacincaptad pegol sodium Inhibitor 98.53% 否
HY-B1350A Fusidic acid sodium salt Inhibitor 99.64% 是
HY-B0111 Drospirenone Agonist 98.45% 否
HY-B0892 Benzyl alcohol 99.96% 否
HY-B1198 Piperonyl butoxide Inhibitor ≥98.0% 否
HY-13859 Clevudine Inhibitor 99.93% 否
HY-N1428A Citric acid monohydrate Inducer ≥98.0% 是
HY-B1268 Docusate Sodium Inhibitor ≥98.0% 否
HY-12752A Alimemazine hemitartrate 98.44% 否
HY-B1640R Ethacrynic acid (Standard) Inhibitor / 否
HY-P0009 Cetrorelix Antagonist / 否
HY-B0430B (±)-Pantothenic acid / 否
HY-B1198R Piperonyl butoxide (Standard) Inhibitor / 否
HY-133171A (S)-Norfluoxetine Inhibitor / 否
抗体抑制剂 (2)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P9944 Palivizumab Inhibitor 99.43% 否
HY-P99797 Pabinafusp alfa 97.49% 否
Clinical Phase
生物活性分子 (17)
目录号 产品名 作用方式
纯度 Phase
HY-N0594 Deacetylasperulosidic Acid Inhibitor 99.86% Phase 4
HY-139994 XN methyl pyrazole Inducer / Phase 4
HY-145721 Mongersen Inhibitor / Phase 3
HY-B1640A Ethacrynic acid sodium / Phase 3
HY-100442 Paquinimod Inhibitor 99.90% Phase 2
HY-141523 Vociprotafib Inhibitor 99.70% Phase 2
HY-10367 Canertinib Inhibitor 99.82% Phase 2
HY-129239 Farudodstat 99.68% Phase 2
HY-14530 Pelitrexol 98.94% Phase 2
HY-112726 PXS-4728A Inhibitor 98.79% Phase 2
HY-18099 S1RA Antagonist 99.43% Phase 2
HY-10367A Canertinib dihydrochloride Inhibitor 99.68% Phase 2
HY-106887 SCH 32615 99.68% Phase 2
HY-115681 (2R/S)-6-PNG Inhibitor 99.88% Phase 1
HY-111792 GSK1795091 Agonist / Phase 1
HY-125639 (rac)-AR-13503 Inhibitor / Phase 1
HY-106925 Cetefloxacin Inhibitor / Phase 1
抗体抑制剂 (2)
目录号 产品名 作用方式
纯度 Phase
HY-P99744 Modakafusp alfa Inhibitor 96.22% Phase 2
HY-P9983 Lintuzumab 98.09% Phase 2
Pre-clinical Phase
生物活性分子 (437)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-14452 Fatostatin Inhibitor 99.96% 否
HY-N0219 Bicuculline Antagonist 99.97% 否
HY-134901 WM-3835 99.78% 否
HY-110171 iMDK Inhibitor 99.35% 否
HY-N2342 Procyanidin C1 Inducer 99.79% 否
HY-131042 NNMTi Inhibitor 99.80% 否
HY-126255 SBI-797812 Activator 99.74% 否
HY-14452A Fatostatin hydrobromide Inhibitor 99.43% 否
HY-137207 MK-28 Activator 99.81% 否
HY-113354 Anserine 99.85% 否
HY-Y0505 Trichloroacetic acid ≥99.0% 否
HY-103017A JH-X-119-01 Inhibitor 99.03% 否
HY-P1925A GO-203 TFA 99.28% 否
HY-B1005 8-Hydroxyquinoline Inhibitor 99.99% 否
HY-111754 DMX-5804 Inhibitor 99.83% 否
HY-103157 PD146176 99.16% 否
HY-114169 WRG-28 Inhibitor 99.34% 否
HY-131181 LEI-401 Inhibitor 99.79% 否
HY-103124 DOI hydrochloride Agonist 99.61% 否
HY-160769 NIBR-LTSi Activator 99.97% 否
HY-143228 SH-42 99.20% 否
HY-P1290A PKA Inhibitor Fragment (6-22) amide TFA Inhibitor 99.77% 否
HY-134494 MS48107 99.85% 否
HY-W010042 L-Glucose 99.88% 否
HY-120912 Gingerenone A Activator 99.70% 否
HY-108559 L-161982 Inhibitor 99.04% 否
HY-117427 D5D-IN-326 Inhibitor 99.60% 否
HY-124284 Hexamethylene bisacetamide 99.56% 否
HY-W013411A Locostatin Inhibitor 99.82% 否
HY-103017 JH-X-119-01 hydrochloride Inhibitor 98.15% 否
HY-141866 Acid Ceramidase-IN-1 99.36% 否
HY-110171A iMDK quarterhydrate Inhibitor 99.37% 否
HY-D0195 Acesulfame potassium 99.38% 否
HY-156856 FL118-14-Propanol 98.69% 否
HY-135747 Gut restricted-7 Inhibitor 98.23% 否
HY-101404A L-Homocysteine thiolactone hydrochloride 99.99% 否
HY-113365 Cholestenone 98.70% 否
HY-P1136B TAT-Gap19 99.47% 否
HY-113412A 3-Methylhistamine dihydrochloride 99.70% 否
HY-145628 CM398 99.85% 否
HY-N6869 Dehydroabietic acid 99.75% 否
HY-P1136C TAT-Gap19 TFA 99.38% 否
HY-103111 MMPIP hydrochloride Antagonist 99.10% 否
HY-147323 Ferulic acid 4-O-sulfate 95.69% 否
HY-19350 BML-210 98.06% 否
HY-N1388 Tussilagone 99.46% 否
HY-W016145 L-Glutamic acid monosodium (hydrate) Inducer ≥98.0% 否
HY-156117 LB244 Inhibitor 98.08% 否
HY-101029 MBM-55 99.94% 否
HY-110190 VU0422288 Modulator 99.88% 否
HY-N0546 Ligustroflavone Antagonist 99.74% 否
HY-12242 GBR 12935 dihydrochloride Inhibitor 99.45% 否
HY-N6962 α-Spinasterol 99.15% 否
HY-116175 BIBB 515 99.44% 否
HY-125130 Hesperetin 7-O-glucoside Inhibitor 98.08% 否
HY-D0887 Disodium 5'-inosinate 99.74% 否
HY-W018723 4-Aminobenzamidine dihydrochloride Inhibitor 99.94% 否
HY-120000 MS402 Inhibitor 99.62% 否
HY-103400 8-Chloroadenosine 99.97% 否
HY-40156 5-Fluoroindole Inhibitor 99.88% 否
HY-128578 KPLH1130 Inhibitor 99.95% 否
HY-N0901A Corynoxine B Inducer 99.76% 否
HY-116818 Crebinostat Inhibitor 99.79% 否
HY-119347 Cirsilineol Inhibitor ≥98.0% 否
HY-12678S1 Entrectinib-d8 99.82% 否
HY-139659 ARD-61 99.68% 否
HY-145721A Mongersen sodium 95.25% 否
HY-156193 PF-07208254 Inhibitor 99.69% 否
HY-N2189 Swertisin 99.75% 否
HY-161305 SE-7552 Inhibitor 99.48% 否
HY-101325 BRL 37344 sodium Agonist 99.90% 否
HY-147222 SAE-14 Antagonist 98.26% 否
HY-155157 PF-07247685 Inhibitor 99.57% 否
HY-164607 YL-5092 Inhibitor 99.83% 否
HY-N5106 (E)-Flavokawain A Inducer 99.79% 否
HY-B1002 Oxolinic acid Inhibitor 98.97% 否
HY-110197 6bK TFA 99.35% 否
HY-121852 SCH 336 Agonist 98.85% 否
HY-127034 Antipain dihydrochloride Inhibitor ≥95.0% 否
HY-155156 PF-07238025 Inhibitor 99.46% 否
HY-160818 MC3138 Activator 99.27% 否
HY-N0506 Rosarin 99.94% 否
HY-N1109 Uvaol 99.18% 否
HY-P3102 GLP-1(32-36)amide 98.42% 否
HY-114918 MS438 Agonist 99.85% 否
HY-120872 AJS1669 free acid Activator 99.15% 否
HY-108497 L-803087 Agonist ≥98.0% 否
HY-129297 CMPF 99.57% 否
HY-14942 Berubicin 87.76% 否
HY-P10032A NN1177 TFA 98.66% 否
HY-120083 Rodatristat Inhibitor 99.11% 否
HY-145774 PD-1/PD-L1-IN-23 Inhibitor 99.88% 否
HY-103290 R715 Antagonist 99.45% 否
HY-120589 VU0360172 Agonist 98.07% 否
HY-136182 YM-244769 dihydrochloride Inhibitor 99.02% 否
HY-145313 TTBK1-IN-2 Inhibitor 99.83% 否
HY-156466 QL-1200186 Inhibitor 99.95% 否
HY-15805 KIN-8194 Inhibitor 98.01% 否
HY-N2787 8-​Prenylnaringenin Inducer 99.34% 否
HY-N3522 Platycoside E Inhibitor 98.66% 否
HY-W248594 IR 813 tosylate 99.47% 否
HY-100384 NKL 22 Inhibitor 97.27% 否
HY-136522 S2116 98.15% 否
HY-101139A Xanthine amine congener hydrochloride Antagonist 98.14% 否
HY-121035 7BIO Inhibitor 99.20% 否
HY-136182A YM-244769 Inhibitor 98.04% 否
HY-143312E (S)-V-0219 hydrochloride Modulator 99.71% 否
HY-143793 RBP4 inhibitor 1 Inhibitor 99.74% 否
HY-144899 ASR-490 Inhibitor 99.05% 否
HY-155478 Androgen receptor-IN-6 Inhibitor 98.26% 否
HY-156120 CD38 inhibitor 3 Inhibitor 98.39% 否
HY-163087 PT-91 98.25% 否
HY-N1503 Methyl deacetylasperulosidate 99.26% 否
HY-P1259A PR-39 TFA Inhibitor 99.96% 否
HY-100442S1 Paquinimod-d5-1 Inhibitor 98.19% 否
HY-100935 Cimaterol Agonist 99.13% 否
HY-107527 Org 25543 hydrochloride Inhibitor ≥99.0% 否
HY-120597 SAK3 Activator 99.44% 否
HY-129087 BC-​1258 Activator 99.26% 否
HY-139973 OAB-14 98.72% 否
HY-N7026 Celosin I 99.36% 否
HY-N7514 Strictosidinic acid Inhibitor / 否
HY-P2203 SAHM1 Inhibitor 96.84% 否
HY-W013411 (E/Z)-Locostatin Inhibitor 99.52% 否
HY-101030A MBM-17S / 否
HY-160023 D3S-001 Inhibitor / 否
HY-132302 Hu7691 Inhibitor / 否
HY-100967 SKF 91488 dihydrochloride Inhibitor 98.62% 否
HY-101325A BRL-37344 Agonist / 否
HY-103327 MJ15 Antagonist 99.78% 否
HY-106947 SY-640 98.62% 否
HY-107659 YM-244769 hydrochloride Inhibitor 99.02% 否
HY-108623 Atizoram Inhibitor 96.3% 否
HY-113354S Anserine-d4 99.38% 否
HY-116392B DL-threo-PDMP hydrochloride Inhibitor 98.4% 否
HY-118282 mPGES1-IN-7 Inhibitor 99.78% 否
HY-120514 JNc-440 98.04% 否
HY-121271 Kadsurin 99.38% 否
HY-12678S Entrectinib-d4 Inhibitor / 否
HY-130136 TMPRSS6-IN-1 Inhibitor / 否
HY-149478 JT002 Inhibitor 99.49% 否
HY-151876 Glucocorticoid receptor modulator 1 99.79% 否
HY-156842 MCAAD-3 96.12% 否
HY-156936 RCB-02-4-8 / 否
HY-157252 CL4F8-6 / 否
HY-162387 UK4b Inhibitor / 否
HY-164495 Sob-AM2 Agonist / 否
HY-21196A Potassium perfluorohexanesulfonate ≥98.0% 否
HY-D1065 NIR-H2O2 / 否
HY-N3204 Neoechinulin A Inhibitor ≥98.0% 否
HY-N5097 13-Oxo-9E,11E-octadecadienoic acid Activator / 否
HY-N8522 9,10-Dihydroxystearic acid ≥98.0% 否
HY-P1302 Orphanin FQ(1-11) Agonist 99.52% 否
HY-P1949A Cyclic MKEY TFA 95.02% 否
HY-P5117 TAT-CIRP Inhibitor 98.32% 否
HY-X0009A JSH-009 dimaleate Inhibitor / 否
HY-12242A GBR 12935 Inhibitor / 否
HY-164546 WB436B / 否
HY-N1428R Citric acid (standard) Inducer / 否
HY-W345885 Saccharic acid Inhibitor ≥97.0% 否
HY-W590683 9A1P9 ≥99.0% 否
HY-101029A MBM-55S / 否
HY-101030 MBM-17 / 否
HY-120667 DS-5272 / 否
HY-12459 Pyrindamycin B Inhibitor / 否
HY-139798 Iboxamycin Inhibitor / 否
HY-132302A Hu7691 free base Inhibitor / 否
HY-153262 KRASG12C IN-2 Inhibitor / 否
HY-B1198S Piperonyl butoxide-d9 Inhibitor / 否
HY-100782 DL-AP7 Antagonist / 否
HY-101699 AMG-076 free base Antagonist / 否
HY-101780A Tinostamustine hydrochloride Inhibitor / 否
HY-103177 PSB-10 hydrochloride Inhibitor / 否
HY-103357 LY288513 Antagonist / 否
HY-103567 Desmethyl-YM-298198 hydrochloride Antagonist / 否
HY-105052 SC 34301 / 否
HY-105236 (Rac)-Enadoline / 否
HY-106837 Israpafant Antagonist / 否
HY-107503 MMPIP Antagonist / 否
HY-107504 VU0360172 hydrochloride Agonist / 否
HY-107567 Carcinine Antagonist / 否
HY-108497A L-803087 TFA Agonist / 否
HY-108538 Ethacrynic acid D5 Inhibitor / 否
HY-110020 rel-O-2050 Antagonist / 否
HY-111315 XEN103 Inhibitor / 否
HY-112636 Astrophloxine Inhibitor 98.34% 否
HY-113354S1 Anserine-d4 hydrochloride / 否
HY-113878 12-OAHSA / 否
HY-113889 ZK112993 Antagonist / 否
HY-114221 Org 48762-0 Inhibitor 99.99% 否
HY-114651 Phenazoviridin / 否
HY-116046 GR 196429 Agonist / 否
HY-116597 L-783483 Agonist / 否
HY-117081 C30(ω-hydroxy) Ceramide (d18:1/30:0) / 否
HY-117603 CM-10-18 Inhibitor / 否
HY-117630 RB-6145 / 否
HY-117836 FAK-IN-16 Inhibitor / 否
HY-118030 RQ-00311651 Antagonist / 否
HY-118032 Bozepinib / 否
HY-118426 (Rac)-Tipifarnib Inhibitor / 否
HY-118574 UBP141 Antagonist / 否
HY-120171 DH-376 Inhibitor / 否
HY-120225 NJK14047 Inhibitor / 否
HY-120561 PC-046 / 否
HY-120769 Pimprinine Inhibitor / 否
HY-120828 Albenatide Agonist / 否
HY-12153 JNJ-1930942 Modulator / 否
HY-121565 SaRI 59-801 / 否
HY-122179 NUCC-555 Antagonist / 否
HY-122309 A-71497 / 否
HY-122398 Janthitrem B / 否
HY-122518 8-Deazafolic acid Inhibitor / 否
HY-122817 FR900098 sodium Inhibitor / 否
HY-122916 7-Acetyllycopsamine / 否
HY-123237 KRC-108 / 否
HY-123357 IMM-H004 Inhibitor / 否
HY-123733A MIP-1095 TFA / 否
HY-124412S Paynantheine-d3 / 否
HY-124557 Mahanimbine / 否
HY-126152 Chlorthiamid / 否
HY-126185 Nibroxane Inhibitor / 否
HY-126910 Mesyl Salvinorin B Agonist / 否
HY-127039 Antipain Inhibitor / 否
HY-129406 AF 698 / 否
HY-130581 Lipid X Inhibitor / 否
HY-131508 M&B 5124 Inhibitor / 否
HY-131954 5-HT3 antagonist 4 Antagonist / 否
HY-133533 O-2050 Antagonist / 否
HY-13659 KRN5500 / 否
HY-138291 Ethoxyquin dimer / 否
HY-143312C (S)-V-0219 Modulator / 否
HY-144668 RdRP-IN-4 Inhibitor / 否
HY-146001 Influenza virus-IN-4 Inhibitor / 否
HY-146151 γ-Secretase modulator 12 / 否
HY-146280 mGAT3/4-IN-1 Inhibitor / 否
HY-146293 HDAC6/HSP90-IN-1 Inhibitor / 否
HY-146297 Xanthine oxidoreductase-IN-2 Inhibitor / 否
HY-146401 CXCR4 antagonist 6 Antagonist / 否
HY-146435 Anti-inflammatory agent 22 Inhibitor / 否
HY-146458 Antibacterial agent 102 Inhibitor / 否
HY-146495 Antitubercular agent-19 Inhibitor / 否
HY-146496 Antitubercular agent-20 Inhibitor / 否
HY-146505 Tubulin polymerization-IN-6 / 否
HY-147335 6,9,12,15-Hexadecatetraenoic acid-ethyl ester / 否
HY-147529 mGluR2 modulator 3 Modulator / 否
HY-147548 Keap1-Nrf2-IN-10 Inducer / 否
HY-147678 GPR40 agonist 5 Agonist / 否
HY-147692 COX-2-IN-14 Inhibitor / 否
HY-148038 5-HT3 antagonist 5 Antagonist 99.75% 否
HY-148617 ALDH2 modulator 1 Modulator / 否
HY-14866 Raseglurant Modulator / 否
HY-149227 IDO1-IN-21 Inhibitor / 否
HY-149240 Anticancer agent 108 Inhibitor / 否
HY-149298 PSMA-IN-2 Inhibitor / 否
HY-149333 BO-1 Inhibitor / 否
HY-149521 PI3K-IN-47 Inhibitor / 否
HY-149776 RGH-560 / 否
HY-149940 SIMR3030 Inhibitor / 否
HY-149975 AMPA receptor modulator-4 Activator / 否
HY-150036 Anthramycin Antagonist / 否
HY-15041 NVP-SAA164 Antagonist / 否
HY-151153 HDAC1-IN-5 / 否
HY-153322 ITK degrader 2 Degrader / 否
HY-155229 CBP/p300-IN-21 Inhibitor / 否
HY-155236 Ancistrotecine B Inhibitor / 否
HY-155328 GK444 Inhibitor / 否
HY-155329 GK718 Inhibitor / 否
HY-155529 FD1024 Inhibitor / 否
HY-155548 RORγt inverse agonist 31 Inhibitor / 否
HY-155652 ABCG2-IN-1 Inhibitor / 否
HY-155682 Antibacterial agent 150 Inhibitor / 否
HY-156276 SP4e Activator / 否
HY-156277 SP4f Activator / 否
HY-156374 D359-0396 Inhibitor / 否
HY-156792 RIOK2-IN-1 / 否
HY-157085 BX-2819 Inhibitor / 否
HY-157211 Anti-inflammatory agent 66 Inhibitor / 否
HY-157326 hMAO-B-IN-6 Inhibitor / 否
HY-157429 25N-N1-Nap Agonist / 否
HY-157430 BET-IN-21 Inhibitor / 否
HY-158006 SDX-7539 Inhibitor / 否
HY-158272 Penicillin/OVA Inhibitor / 否
HY-158434 IRAK1-IN-1 Inhibitor / 否
HY-158649 Fasnall benzenesulfonate / 否
HY-159131 PNSC928 Inhibitor / 否
HY-159602 BET BD2-IN-3 Inhibitor / 否
HY-159891 Microtubule destabilizing agent-2 / 否
HY-159895 PAR4 antagonist 7 Antagonist / 否
HY-159941 tau-0N4R-IN-1 Inhibitor / 否
HY-159942 5-HT7R antagonist 3 / 否
HY-159972 PKR1 antagonist 1 Antagonist / 否
HY-160025 IDO antagonist-1 Antagonist / 否
HY-160237 HYL001 Inhibitor / 否
HY-161281 α-Glucosidase-IN-49 Inhibitor / 否
HY-161372 PARP1/c-Met-IN-1 / 否
HY-161373 PI3Kα-IN-22 Inhibitor / 否
HY-161458 GSK-3β inhibitor 16 / 否
HY-161671 GAT2711 Agonist / 否
HY-161781 HVH-2930 Inhibitor / 否
HY-161853 TX-2552 99.69% 否
HY-161860 Antibacterial agent 233 Inhibitor / 否
HY-161863 Tubulin polymerization-IN-67 / 否
HY-161887 SMARCA2-IN-8 Inhibitor / 否
HY-161890 Antimycobacterial agent-8 Inhibitor / 否
HY-161893 Anti-MRSA agent 15 Inhibitor / 否
HY-161901 BC-1293 Inhibitor / 否
HY-162406 UNC8969 / 否
HY-162428 PTPN2/1-IN-3 Inhibitor / 否
HY-162596 NRL-1049 Inhibitor / 否
HY-162655A SLF80821178 hydrochloride Inhibitor / 否
HY-162683 (S)-PHA533533 Inhibitor / 否
HY-162703 Lipid-lowering agent-2 Activator / 否
HY-162727 GCS-12 / 否
HY-162751 Anticancer agent 249 / 否
HY-162760 COMT-IN-1 Inhibitor / 否
HY-162765 TRPV4-IN-5 Inhibitor / 否
HY-162866 CXM102 Activator / 否
HY-162867 Photosensitizer-5 Inducer / 否
HY-162879 FAK inhibitor 7 / 否
HY-162893 SX29 Inhibitor / 否
HY-163003 Antitrypanosomal agent 19 Inhibitor / 否
HY-163066 α-Glucosidase-IN-44 Inhibitor / 否
HY-163300 NLRP3-IN-30 Inhibitor / 否
HY-163320 AChE/Aβ-IN-5 Inhibitor / 否
HY-163345 5-HT7R antagonist 2 Antagonist / 否
HY-163363 β-AR antagonist 2 Antagonist / 否
HY-163482 ELQ-596 Inhibitor / 否
HY-163484 ELQ-650 Inhibitor / 否
HY-163651 (R)-Vorbipiprant Antagonist / 否
HY-163782 SMIP-031 / 否
HY-163797 WRN inhibitor 10 Inhibitor / 否
HY-163799 PRMT5-MTA-IN-1 Inhibitor / 否
HY-163816 Antiproliferative agent-53-d3 Inhibitor / 否
HY-163817 PARP1/2-IN-3 Inhibitor / 否
HY-163885 SSZ Inhibitor / 否
HY-163906 Anti-MRSA agent 16 Inhibitor / 否
HY-163978 YGZ-331 Activator / 否
HY-164397 XMU-MP-5 / 否
HY-168021 MAO-A/SERT-IN-1 Inhibitor / 否
HY-168031 AChE/BChE-IN-21 / 否
HY-168629 FXR agonist 9 Inhibitor / 否
HY-169007 STAT3-IN-34 Inhibitor / 否
HY-169018 CIB-1476 Inhibitor / 否
HY-169019 XJTU-L453 / 否
HY-169037 Δ8-Tetrahydrocannabinoquinone Inducer / 否
HY-169104 InhA-IN-8 Inhibitor / 否
HY-169240 MX69-102 Activator / 否
HY-169394 5-HT1AR agonist 2 / 否
HY-18164 TASP0277308 Antagonist / 否
HY-19015 Probimane / 否
HY-40156A Mycobacterium Tuberculosis-IN-5 Inhibitor / 否
HY-B0448S Phenytoin-d10 Inhibitor ≥98.0% 否
HY-B1002R Oxolinic acid (Standard) Inhibitor / 否
HY-B1002S Oxolinic acid-d5 Inhibitor 98.0% 否
HY-D1066 NIR-Thiol dinitrobenzenesulfonate / 否
HY-D1535 IR 813 perchlorate / 否
HY-D2095 Medical fluorophore 33 / 否
HY-D2203 BODIPY BDP4 / 否
HY-N10359 Isoandrographolide Inhibitor / 否
HY-N11021 Feruloyl tyramine / 否
HY-N12042 Taxamairin B Inhibitor / 否
HY-N12124 Monascuspiloin / 否
HY-N12249 7-Deoxy-trans-dihydronarciclasine Inhibitor / 否
HY-N12353 Stevisalioside A Inhibitor / 否
HY-N4243 Neocurdione / 否
HY-N5126 Juncusol / 否
HY-N7047 8-Epidiosbulbin E acetate Inhibitor 98.42% 否
HY-N7944 Eucommiol / 否
HY-N9173 Cupressuflavone / 否
HY-N9794 Isoboldine / 否
HY-P10032 NN1177 / 否
HY-P10057 cpm-1285 Inducer / 否
HY-P10110 retro-inverso TAT-Beclin 1 (D-amino acid) Inducer / 否
HY-P10721 Plectasin Inhibitor / 否
HY-P1259 PR-39 Inhibitor / 否
HY-P1290 PKA Inhibitor Fragment (6-22) amide Inhibitor / 否
HY-P1302A Orphanin FQ(1-11) TFA Agonist / 否
HY-P1949 Cyclic MKEY / 否
HY-P3102A GLP-1(32-36)amide TFA / 否
HY-P3707 Tumor targeted pro-apoptotic peptide Inducer / 否
HY-P4641 H-Trp-Phe-OH Inhibitor / 否
HY-P5890 YVAD-CHO Inhibitor / 否
HY-RS08425 MICAL1 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-W009688 Dibutyl maleate 98.80% 否
HY-W040276 Diafen NN / 否
HY-W097106 (S)-3-N-Cbz-Amino-succinimide / 否
HY-W677042 α-Androstenol Modulator / 否
HY-W795264 FR900098 Inhibitor / 否
HY-100442S Paquinimod-d5 Inhibitor / 否
HY-100840 (S)-4C3HPG / 否
HY-100922 N-Acetylglycyl-D-glutamic acid / 否
HY-101699A AMG-076 Antagonist / 否
HY-101775 9-Hydroxyellipticin Inhibitor / 否
HY-103163 (±)-5'-Chloro-5'-deoxy-ENBA Agonist / 否
HY-103388 NCX 466 Inhibitor / 否
HY-103567A Desmethyl-YM-298198 Antagonist / 否
HY-105969 Dichloromethotrexate / 否
HY-107567B Carcinine dihydrochloride Antagonist / 否
HY-114853 BVT.13 Agonist / 否
HY-114992 2-Propyl-2-pentenoic acid / 否
HY-116799 NSC 145669 Inhibitor / 否
HY-117446 AS-1669058 Agonist / 否
HY-117569 KF24345 free base Inhibitor / 否
HY-118537 ICI 56780 Inhibitor / 否
HY-118803 AS1468240 Inhibitor / 否
HY-119218 LH 1 / 否
HY-119519 OB-2 / 否
HY-119899 BO-0742 / 否
HY-119955 Amflutizole Inhibitor / 否
HY-120450 CL-55 Inhibitor / 否
HY-120462 Genz-669178 Inhibitor / 否
HY-121431 FR-901235 / 否
HY-122655 HMCEF Inhibitor / 否
HY-123020 CYD-2-88 / 否
HY-124499 RUC-1 Inhibitor / 否
HY-12580 RO5353 MDM2 Inhibitor / 否
HY-12610 Carbonic anhydrase inhibitor 27 Inhibitor / 否
HY-126170 Valanimycin Inhibitor / 否
HY-129318 MBX-1066 Inhibitor / 否
HY-129347 Lankacyclinol A Inhibitor / 否
HY-134579 Chaetomellic acid A Inhibitor / 否
HY-138100 Hyalodendrin Inhibitor / 否
HY-160554 C12-113 / 否
HY-161728 Antibacterial agent 223 Inhibitor / 否
HY-161935 6-(12-Tridecene-1-yl)-2,4-Dihydroxy benzoic acid Inhibitor / 否
HY-161937 Antibacterial agent 236 Inhibitor / 否
HY-164384 DFX117 / 否
HY-164462 BHA536 / 否
HY-164478 G-631 Inhibitor / 否
HY-164547 WHN-88 Inhibitor / 否
HY-B2085 Arsthinenol / 否
HY-N11681 Microcystin-WR / 否
HY-N12719 Isocampneoside I / 否
HY-N9484S Menthofuran-13C2 / 否
HY-P10200 CP7-FP13-2 Inhibitor / 否
HY-P4885 Glp-amyloid-β (3-40) peptide (human) / 否
HY-W369099 HJC0152 free base / 否
抗体抑制剂 (1)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P99620 Firivumab Inhibitor 95.00% 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Mical1 NCBI NCBI:64780
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z